# MetaVia Inc. (MTVA)

> Source: Nexqual · https://nexqual.com/MTVA · data as of 2026-10-15 20:00 UTC · cite as "Nexqual, MetaVia Inc. (MTVA), nexqual.com/MTVA" · informational, not investment advice.

**Price:** USD 1.37 (+0.74% on the day) · last close of Oct 15, 2026; US market closed, not a live price. Prev close 1.36 · day 1.33–1.44 · 52w 0.97–14.85 · market cap $9.0M · NCM

## Key facts
- Total return with dividends: 1Y -88.0% vs S&P 500 +18.1%; 5Y -100.0% vs S&P 500 +85.1%.

## Analysts
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-07-10 | HC Wainwright & Co. | Reiterated | Buy | $20 |

## Total return (dividends reinvested)
|  | 1Y (from 2025-10-16) | 5Y (from 2021-10-11) |
|---|---|---|
| Total return | -88.0% | -100.0% |
| S&P 500 (SPY) | +18.1% | +85.1% |
| Per year | -88.1% | -80.5% |
| Volatility (annualized) | 142.5% | 132.4% |
| Max drawdown | -91.8% (Nov 2025→May 2026) | -100.0% (Nov 2021→May 2026) |

## Peers (Biotechnology)
RYTM (Rhythm Pharmaceuticals, Inc.) USD 87.97 +1.57% · BLTE (Belite Bio, Inc) USD 152.62 +0.49% · IOVA (Iovance Biotherapeutics, Inc.) USD 14.72 +1.52% · PRAX (Praxis Precision Medicines, Inc) USD 248.24 +2.01% · IONS (Ionis Pharmaceuticals, Inc.) USD 44.12 +4.11% · SYRE (Spyre Therapeutics, Inc.) USD 80.1 -0.44%

## More
Full page: https://nexqual.com/MTVA · Free keyless MCP server with the same data and citations: https://mcp.nexqual.com/mcp · Guide for agents: https://nexqual.com/agents · https://nexqual.com/llms.txt